The four-year-old firm's latest fund is 60% larger than its second vehicle announced 18 months ago.

One of Rhode Island's most-wanted fugitives was arrested in New York last week after being on the run for more than 20 years, which was at least partially spent hiding as a biotech executive, according to Stat News.

In a Securities and Exchange Commission filing Monday, California-based Immix Biopharma noted that Richard Graydon was terminated Friday for "reasons unrelated to his activities at the Company."

It turns out, Richard Graydon was an alias for Ronald Fischer, a 70-year-old former anesthesiologist licensed in Rhode Island and Massachusetts, who fled amid his 2005 trial for first-degree sexual assault. Fischer was accused of raping a woman during a date on his yacht, Lion King.

Read full article

Comments

© Rhode Island State Police

Gidi Littwin’s new AI startup, Hemispheric, makes diagnostic brain scans for conditions like depression, PTSD, and Parkinson’s. He wants the technology to be as cheap and easy as for a blood test.

Researchers cobbled together funding and time to show how quantum computing could aid in the development of drugs to help underserved populations and combat rare diseases.

Listen to the session or watch below

Billions of dollars are flooding into efforts to reverse aging as scientists explore ways to return cells to a younger state. But how far off are these experimental treatments? Will they really work? Watch a conversation exploring longevity’s new focus.

Speakers: Mary Beth Griggs, science editor and Jessica Hamzelou, senior biotechnology reporter

Recorded on June 30, 2026

Related Stories:

• Why “reprogramming” is the buzziest approach to reversing aging right now
• How scientists want to make you young again
• Sam Altman invested $180 million into a company trying to delay death